Search results
Results from the WOW.Com Content Network
APS – TEVA UK Ltd; Assertio – Assertio Therapeutics, Inc; AstraZeneca – AstraZeneca UK Limited; Aventis Pharma – Sanofi-Aventis Ltd; Bausch & Lomb – Bausch & Lomb UK Ltd; Baxter – Baxter International; Baxter BioScience – Baxter International; Bayer – Bayer plc (Pharmaceutical Division) Becton Dickinson – Becton Dickinson UK Ltd
AstraZeneca's primary listing is on the London Stock Exchange and is a constituent of the FTSE 100 Index; it also has a secondary listing on the Nasdaq Stockholm. It is also listed on the American Nasdaq and is a Nasdaq-100 company. AstraZeneca has one of the highest market capitalisations of pharmaceutical companies worldwide. [13]
Jane Osbourn, OBE, is a scientist and former chair of the UK BioIndustry Association. [1]A Natural Sciences graduate of Queens' College, Cambridge, Osbourn completed several post-graduate qualifications before moving into industry at Cambridge Antibody Technology, that became MedImmune and AstraZeneca.
The UK is home to GlaxoSmithKline and AstraZeneca, respectively the world's fifth- and sixth-largest pharmaceutical companies measured by 2009 market share. [8] It is also home to the multinational Hikma Pharmaceuticals. Foreign companies with a major presence in the UK pharmaceutical industry include Pfizer, Novartis, [9] Hoffmann–La Roche ...
Li Ka Shing Centre of the Cancer Research UK Cambridge Institute. The Cancer Research UK Cambridge Institute is one of four core funded Cancer Research UK Institutes [11] and a department of the University of Cambridge. In 2018, the department received an annual budget of £45 million, £27.8 million of which came from Cancer Research UK.
Cambridge Science Park Cambridge Business Park St John's Innovation Centre Peterhouse Technology Park Melbourn Science Park Granta Park Cambourne Business Park. Silicon Fen or the Cambridge Cluster is a collective name given to high tech businesses focused on software, electronics, and biotechnology, including Arm and AstraZeneca, in and around the city of Cambridge in England.
The International Graduates Scheme (IGS) was a UK immigration scheme which was launched on 2 May 2007 and ended on 30 June 2008, when it was replaced by Tier 1 (Post Study Work). It allowed non- EEA nationals who successfully complete a relevant UK degree or postgraduate qualification to work or set up a business in the UK for 12 months without ...
Zeneca (officially Zeneca Group PLC) was a British multinational pharmaceutical company headquartered in London, United Kingdom.It was formed in June 1993 by the demerger of the pharmaceuticals and agrochemicals businesses of Imperial Chemical Industries into a separate company listed on the London Stock Exchange.